CClinicalTrials.gg
Status unknownNCT03601403Updated Dec 6, 2018

Tablet-assisted Training in Exacerbated COPD

An interventional study of inhaler technique in Chronic Obstructive Pulmonary Disease, sponsored by Universidad de Granada. Status unknown at 1 site in Spain. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2018-12-06.

Sponsored by Universidad de Granada · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Dec 2018), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Dec 2017, registered Jul 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
42
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

Chronic obstructive pulmonary disease (COPD) is a public health problem with great morbidity. The main therapeutic strategy is inhalers. The objective of this study is to determine the efficacy of a tablet-assisted training in the use of inhalers in patients with COPD including ventilatory re-education and video recordings of the patients themselves.

Read the detailed description

The importance of this pathology lies not only in its high prevalence, which is expected to increase due to the aging of society but also in its high mortality. In Europe, it is estimated that 50% of adult patients do not use the inhaler correctly. The clinical development of COPD includes periods of stability interspersed with symptomatic exacerbations, which usually involve hospitalization. During these hospitalizations, respiratory symptoms are worsening.Nevertheless, in Europe, it is estimated that 50% of adult patients do not use the inhaler correctly. Thus, it is very important the pharmacological education in this patients.

02

Conditions studied

  • Chronic Obstructive Pulmonary Disease

Keywords

  • Education
  • Dry Powder Inhalers
  • Metered Dose Inhalers
  • Pulmonary Disease
  • Chronic Obstructive
03

In context

Lung Diseases

3,303 studies on the registry are indexed under Lung Diseases; 355 are open to participants now.

This study's planned enrollment of 42 is below the median of 72 across 2,118 interventional studies indexed under Lung Diseases.

Browse Lung Diseases studies →

Lead sponsor

Universidad de Granada is the lead sponsor of 241 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed of exacerbation of COPD.
  • To possess pharmacological treatment in the form of inhalers.

Exclusion criteria

Exclusion Criteria:

  • Inability to provide informed consent.
  • Presence of psychiatric or cognitive disorders.
  • Organ failure or cancer.
  • Inability to cooperate.
  • Patients who had experienced an exacerbation in the last month.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
42 participants (estimated)

Study arms

  • No intervention
    CONTROL GROUP

    Received the standard medical and pharmacological care provided by the hospital

  • Experimental
    Inhaler technique

    The intervention group received the standard medical and pharmacological care provided by the hospital. In addition, a tablet-assisted training on the use of inhalers, which included an explanation of the use of inhalers together with a ventilatory re-education program.

    Device: inhaler technique

Interventions

  • Deviceinhaler technique

    The first day of the intervention consisted primarily of ventilatory re-education. During the realization of the technique, he was videotaped with a Tablet so that later the patient could be seen and on the video to be able to give him the guidelines for the correction. On the second and third day of the intervention, ventilation re-education was performed and the inhalation technique was subsequently trained.

06

What researchers measure

Primary outcomes

  1. Forced expiratory volume in the first second (FEV1)

    Changes from baseline to postintervention in FEV1vas evaluated by a spirometer.

    Time frame: [Time Frame: baseline, 12 months]

Secondary outcomes

  1. Knowledge of the Chronic Obstructive Pulmonary Disease

    Evaluated at baseline by Chronic Obstructive Pulmonary Disease Questionnaire (COPD-Q). COPD knowledge was evaluated using the Chronic Obstructive Pulmonary Disease Knowledge Questionnaire (COPD-Q; Maples, Franks, Ray, Stevens, \& Wallace, 2010). The COPD-Q is a valid, readable, and reliable 13-item (each one score 0 to 3) self-administered true/false questionnaire assessing COPD knowledge in patients with low health literacy skills. A higher punctuation indicates better results.

    Time frame: [Time Frame: Baseline, 12 months]

  2. Cognitive Level

    Cognitive level was assessed using the Montreal Cognitive Assessment (MOCA).

    Time frame: [Time Frame: Baseline]

  3. Functional independence

    Functional independence was assessed using the Functional Independence Mease Scale (FIM). This scale has 18 items that are grouped into 2 dimensions, 13 motor items, and 5 cognitive items. The total score range between 18 points (total dependence) to 126 points (Independence completes).

    Time frame: [Time Frame: Baseline]

  4. Anxiety-depression level

    Changes from baseline to postintervention in anxiety and depression measured with the Hospital Anxiety and Depression Scale. Patients are going to complete this questionnaire composed of statements relevant to either generalized anxiety or depression. It is composed of 14 items, 7 for anxiety and 7 for depression and higher values are related to higher depression and anxiety.

    Time frame: [Time Frame: Baseline, 12 months]

  5. Adhesion to inhalers

    Level of adhesion to inhalers was assessed with TAI (Inhaler Adhesion Test).

    Time frame: [Time Frame: Baseline]

  6. Dyspnea level

    Perceived perception of dyspnea was collected through the Modified Borg Scale. Patients have to choose a number between 0 ( no dyspnea) to 10 (higher dyspnea).

    Time frame: [Time Frame: Baseline]

  7. Physical fitness

    Physical fitness was assessed by performing the five-times-sit-to-stand test. It consists of getting up and sitting five times in a row without a support. The time period in which the exercise is performed is the patient's score with a maximum of 60 seconds

    Time frame: [Time Frame: baseline, 12 months]

  8. Technique of the inhaler

    The evaluation of the technique of the inhalers was carried out by means of a checklist composed of 5 items. Checked those points that were done correctly obtaining 5 points if the technique that was done correctly.

    Time frame: [Time Frame: baseline, 12 months]

  9. Pressure expiratory force (PEF)

    Changes from baseline to postintervention in PEF were assessed using a peak flow.

    Time frame: [Time Frame: baseline, 12 months]

07

Study locations

1 site
  • Faculty of Health Sciences. University of Granada.
    Granada., Granada 18071, Spain
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03601403
Lead sponsor
Universidad de Granada
Responsible party
Marie Carmen Valenza (Principal investigator, Universidad de Granada) — Principal investigator
First posted
Jul 26, 2018
Start date
Dec 1, 2017
Primary completion
Jun 23, 2018
Completion
Apr 2019 (estimated)
Last update
Dec 6, 2018

Study contacts

M. Carmen Valenza, PH MD
principal investigator · Department of Physical Therapy. University of Granada.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion